Упрощенная HTML-версия
128
187. Vogel R.A. Coronary risk factors, endothelial function, and athero-
sclerosis: a review / R.A. Vogel // Clin Cardiol. – 1997. – V.20. – P. 426-432.
188. Walder K. Leptin inhibits insulin binding in isolated rat adipocytes /
K. Walder, A. Pilippis, S. Clark et al. // J. Endocrinol. – 1997. – V. 155. – P. R5-
R7.
189. Welborn T. A. Serum-insulin in essential hypertension and in pe-
ripheral vascular disease / T.A. Welborn, A. Breckenridge, A.H. Rubinstein et al.
// Lancet. – 1966. – V.1. – P. 1136-1137.
190. Willix A.L. Antiatherosclerotic effects of nicardipine and nifedipine
in cholesterol-fed rabbits / A.L. Willix, B. Nagel, V. Churchill el al. // Arterio-
sclerosis. –1985. – V. 5. – P. 250-255.
191. World Health Organization. Obesity: preventing and managing the
global epidemic of obesity. // Report of the WHO Consultation of Obesity. Gene-
va, 3-5 June 1997.
192.
Zanchetti A. Risk assessment and treatment benefit in intensively
treated hypertensive patients of the Hypertension Optimal Treatment (HOT)
study for the HOT Study Group / A. Zanchetti, L. Hansson, J. Menard // J. Hy-
pertens. – 2001. – V. 19. – P. 819-825.
193.
Zeiher A.M. Long-term cigarette smoking impairs endotheliu in-
dependent coronary arterial vasodilator function / A.M. Zeiher, V. Schachinger,
Minnenf. // Circulation. – 1995. – V.92. – P. 1094-1100.
194.
Zimmet P. Serum leptin concentration, obesity, and insulin re-
sistance in Western Samoans: cross sectional study / P. Zimmet, A. Hodge, M.
Nicolson et al
.
// Br. Med. J. – 1996. – V.313. – P. 965-969.
195.
Zimmet P.Z. Is there a relationship between leptin and insulin sensi-
tivity independent of obesity? A population-based study in the Indian Ocean na-
tion of Mauritius / P.Z. Zimmet, V.R. Collins, M.P. Courten et al
.
// Int. J. Obesi-
ty. – 1998. – V. 21. – P.171-177.